trovafloxacin has been researched along with Bacterial Infections, Gram-Negative in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brighty, KE; Gootz, TD | 1 |
| Gootz, TD; Pechère, JC | 1 |
| Seifert, H | 1 |
| Bjarnason, J; Blondeau, JM; Laskowski, R; Stewart, C | 1 |
2 review(s) available for trovafloxacin and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
The chemistry and biological profile of trovafloxacin.
Topics: Animals; Anti-Infective Agents; Bacteria, Anaerobic; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Guinea Pigs; Humans; Macaca fascicularis; Mice; Microbial Sensitivity Tests; Naphthyridines; Rabbits; Structure-Activity Relationship | 1997 |
Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Naphthyridines; Respiratory System; Respiratory Tract Infections | 1998 |
2 other study(ies) available for trovafloxacin and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria, Aerobic; Bacterial Infections; beta-Lactams; Blood; Culture Media; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Naphthyridines | 1998 |
Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms.
Topics: Anti-Infective Agents; Aza Compounds; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines | 2000 |